Is LMNL or BTI a better dividend investment in 2026?

LMNL currently yields 23.53% with a 5% 5-year dividend growth rate. BTI yields 5.38% with 5% growth. The better choice depends on your goal: LMNL offers higher current income.

What is the dividend yield difference between LMNL and BTI?

LMNL has a forward dividend yield of 23.53% ($2.00/share annually). BTI yields 5.38% ($3.15/share annually). The yield gap is 18.15 percentage points.

Home › Compare › LMNL vs BTI

LMNL vs BTI: Dividend Comparison 2026

LMNL yields 23.53% · BTI yields 5.38%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 LMNL wins by $52.7K in total portfolio value

INVESTMENT

TIME HORIZON10 years

LMNL

● Live price

23.53%

Share price

$8.50

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$90.5K

Annual income

$9,663.72

Full LMNL calculator →

BTI

● Live price

5.38%

Share price

$58.47

Annual div

$3.15

5Y div CAGR

11.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$37.7K

Annual income

$2,786.64

Full BTI calculator →

Portfolio growth — LMNL vs BTI

📍 LMNL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	LMNL	BTI
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, LMNL + BTI cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

LMNL pays

BTI pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LMNL

Annual income on $10K today (after 15% tax)

$2,000.00/yr

After 10yr DRIP, annual income (after tax)

$8,214.16/yr

BTI

Annual income on $10K today (after 15% tax)

$457.40/yr

After 10yr DRIP, annual income (after tax)

$2,368.64/yr

At 15% tax rate, LMNL beats the other by $5,845.52/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LMNL + BTI for your $10,000?

LMNL: 50%BTI: 50%

100% BTI50/50100% LMNL

Portfolio after 10yr

$64.1K

Annual income

$6,225.18/yr

Blended yield

9.71%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

LMNL

Analyst Ratings

Hold

Consensus: Hold

Altman Z

-49.8

Piotroski

5/9

BTI

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$40.00

-31.6% upside vs current

Range: $40.00 — $40.00

Altman Z

2.1

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LMNL buys

BTI buys

No recent congressional trades found for LMNL or BTI in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricLMNLBTI

Forward yield	23.53% ✓	5.38%
Annual dividend / share	$2.00	$3.15 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	11.3% ✓
Portfolio after 10y	$90.5K ✓	$37.7K
Annual income after 10y	$9,663.72 ✓	$2,786.64
Total dividends collected	$55.7K ✓	$14.3K
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples
Analyst consensus	Hold	Buy

Year-by-year: LMNL vs BTI ($10,000, DRIP)

Year	LMNL Portfolio	LMNL Income/yr	BTI Portfolio	BTI Income/yr	Gap
1← crossover	$13,053	$2,352.94	$11,299	$598.92	+$1.8K → LMNL
2	$16,837	$2,870.36	$12,794	$703.91	+$4.0K → LMNL
3	$21,476	$3,460.26	$14,518	$829.07	+$7.0K → LMNL
4	$27,104	$4,124.87	$16,513	$978.64	+$10.6K → LMNL
5	$33,867	$4,865.30	$18,827	$1,157.84	+$15.0K → LMNL
6	$41,919	$5,681.51	$21,518	$1,373.12	+$20.4K → LMNL
7	$51,425	$6,572.30	$24,657	$1,632.46	+$26.8K → LMNL
8	$62,561	$7,535.33	$28,329	$1,945.74	+$34.2K → LMNL
9	$75,507	$8,567.24	$32,637	$2,325.33	+$42.9K → LMNL
10	$90,456	$9,663.72	$37,708	$2,786.64	+$52.7K → LMNL

LMNL vs BTI: Complete Analysis 2026

LMNL — Stock

Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the treatment of idiopathic pulmonary, liver, cardiac, or skin fibrosis with fezagepras or related derivatives and respiratory diseases. It is also developing antagonist candidate programs, including G-protein coupled receptor 84 and Oxo-eicosanoid receptor 1, which are in preclinical stage. The company was formerly known as Prometic Life Sciences Inc. and changed its name to Liminal BioSciences Inc. in October 2019. Liminal BioSciences Inc. was incorporated in 1994 and is headquartered in Laval, Canada.

Full LMNL Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →

📬

Get this LMNL vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LMNL vs SCHD LMNL vs JEPI LMNL vs O LMNL vs KO LMNL vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.